1. Home
  2. LICN vs TXMD Comparison

LICN vs TXMD Comparison

Compare LICN & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lichen China Limited

LICN

Lichen China Limited

HOLD

Current Price

$2.91

Market Cap

53.1M

Sector

N/A

ML Signal

HOLD

Logo TherapeuticsMD Inc.

TXMD

TherapeuticsMD Inc.

HOLD

Current Price

$1.66

Market Cap

21.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LICN
TXMD
Founded
2004
2008
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.1M
21.3M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
LICN
TXMD
Price
$2.91
$1.66
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
64.0K
55.3K
Earning Date
12-19-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.03
Revenue
$37,641,000.00
$2,796,000.00
Revenue This Year
N/A
$427.09
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$275.53
Revenue Growth
N/A
75.19
52 Week Low
$2.57
$0.70
52 Week High
$56.42
$2.44

Technical Indicators

Market Signals
Indicator
LICN
TXMD
Relative Strength Index (RSI) 40.70 50.93
Support Level $3.03 $1.64
Resistance Level $3.19 $1.78
Average True Range (ATR) 0.28 0.14
MACD -0.01 -0.02
Stochastic Oscillator 11.46 12.55

Price Performance

Historical Comparison
LICN
TXMD

About LICN Lichen China Limited

Lichen International Ltd is a financial and taxation service provider in China. The company provides financial and taxation solution services; education support services; and software and maintenance services in the PRC under its Lichen brand. The financial and taxation solution services comprise financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation. The education support services comprise the provision of marketing, operational and technical support and the sales of teaching and learning materials. The software and maintenance services comprise the sales of financial and taxation analysis software and sales of financial and taxation training software.

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

Share on Social Networks: